Upper Gastrointestinal Tract, Head and Neck, Lung
Colorectal Carcinoma Locally Advanced
Advanced Metastatic Melanoma
Advanced Solid Tumors
Newly Diagnosed, Refractory or Relapsed
Mantle Cell Lymphoma
Metastatic Carcinoid Tumors
Multiple Myeloma
Metastatic Breast Cancer
Dukes C Colon Cancer
Unresectable Stage III or Stage IV Melanoma
Advanced Colorectal Cancer
Acute Myeloid Leukemia (AML)
Chronic Myeloid Leukemia (CML)

Tumor eradication and increased quality of life are the primary objectives of today’s oncology therapeutics and devices. ProClinical Research Consultants understand how important it is to capture unexpected and expected adverse events to control and mitigate associated toxicities while increasing the probability of tumor reduction.

Our consultants verify and scrutinize to confirm the site’s documented measurements ensuring the accuracy of the data. We track concomitant medications, prohibited medications and deviations that assist bio-statisticians, scientists, safety and key opinion leaders (KOLs) in determining best dosing regimens. We identify protocol infractions early to prevent deviation trends and ensure patient safety.

ProClinical Research Consultants are routinely trained and updated on novel and contemporary therapeutic agents. Operating on the forefront of the most recent scientific breakthroughs, we offer practical, comprehensive skills that ensure the study data is clean, concise and traceable.